Cell Therapy in Patients with Critical Limb Ischemia
- PMID: 26300924
- PMCID: PMC4537766
- DOI: 10.1155/2015/931420
Cell Therapy in Patients with Critical Limb Ischemia
Abstract
Critical limb ischemia (CLI) represents the most advanced stage of peripheral arterial obstructive disease (PAOD) with a severe obstruction of the arteries which markedly reduces blood flow to the extremities and has progressed to the point of severe rest pain and/or even tissue loss. Recent therapeutic strategies have focused on restoring this balance in favor of tissue survival using exogenous molecular and cellular agents to promote regeneration of the vasculature. These are based on stimulation of angiogenesis by extracellular and cellular components. This review article carries out a systematic analysis of the most recent scientific literature on the application of stem cells in patients with CLI. The results obtained from the detailed analysis of the recent literature data have confirmed the beneficial role of cell therapy in reducing the rate of major amputations in patients with CLI and improving their quality of life.
Figures
References
-
- Simons J. P., Goodney P. P., Nolan B. W., Cronenwett J. L., Messina L. M., Schanzer A. Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. Journal of Vascular Surgery. 2010;51(6):1419–1424. doi: 10.1016/j.jvs.2010.01.083. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
